Evidence map›Paper›PMID 10559384›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience1999

Cell type-specific activation of neuronal nicotinic acetylcholine receptor subunit genes by Sox10.

Q Liu, I N Melnikova, M Hu, P D Gardner

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Long noncoding RNA GM12371 acts as a transcriptional regulator of synapse function.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Q LiuDepartment of Molecular Medicine, University of Texas Health Science Center, San Antonio, Texas 78245-3207, USA.
I N Melnikova
M Hu
P D Gardner
The University of Texas Health Science Center at San Antonio · US

Funding

MOLECULAR ANALYSIS OF NEURONAL ACH RECEPTOR EXPRESSIONR01NS030243 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GARDNER, PAUL D · 1991 to 2009
$2.6M
NINDS NIH HHS R01 NS030243
6 · The paper itself

Abstract

The regulatory factor Sox10 is expressed in neural crest derivatives during development as well as in the adult CNS and peripheral nervous system. Mutations of the human Sox10 gene have been identified in patients with Waardenburg-Hirschsprung syndrome that is characterized by defects in neural crest development. Previous studies suggested that Sox10 might function as an important transcriptional regulator of neural crest development. No natural target genes of Sox10 have yet been identified. Although human Sox10 activates a synthetic promoter consisting of a TATA box and multiple Sox consensus sequences, no transcriptional activity of the rat Sox10 homolog has been detected. Here we report that the neuronal nicotinic acetylcholine receptor beta4 and alpha3 subunit gene promoters are transactivated by rat Sox10 in a cell type-specific manner. The alpha3 and beta4 subunits, in combination with the alpha5 subunit, make up the predominant nicotinic receptor subtype expressed in the peripheral nervous system. Transfections using Sox10 mutants indicate that the C-terminal region is dispensable for its ability to activate the beta4 and alpha3 promoters. Rat Sox10 was originally identified as an accessory protein of the POU domain protein Tst-1/Oct6/SCIP in glial cells. Tst-1/Oct6/SCIP was shown previously to activate the alpha3 promoter. We now demonstrate that it can transactivate the beta4 promoter as well. However, we were unable to detect any synergistic effects of Sox10 and Tst-1/Oct6/SCIP on beta4 or alpha3 promoter activity. Finally, we present data suggesting that recombinant Sox10 protein can directly interact with a previously characterized regulatory region of the beta4 gene.

Indexed as

Promoter Regions, GeneticTranscriptional Activation3T3 CellsAnimalsBase SequenceCell LineDNA-Binding ProteinsGene Expression RegulationHeLa CellsHigh Mobility Group ProteinsHumansMiceMutagenesis, Site-DirectedNeurogliaNeuronsPC12 CellsDNA-Binding ProteinsHigh Mobility Group ProteinsReceptors, NicotinicRecombinant Fusion ProteinsSOX10 protein, humanSox10 protein, mouseSox10 protein, ratSOXE Transcription FactorsTranscription Factors

Identifiers

PMID10559384
PMCPMC6782953
OpenAlexW1937095862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.